Ranbaxy readies relaunch of banned skin products; Hedge funder ups Mylan stake to $575M;

 @FiercePharma: Potentially good for hep C drugmakers: CDC calls for all boomers to get tested. Could ID 800K cases--Bloomberg. More | Follow @FiercePharma

> Four years after its skin product line Sotret was barred from the U.S. market, Ranbaxy Laboratories is preparing to relaunch in partnership with Canada's Cipher Pharmaceuticals. Report

> Hedge fund chief John Paulson raised his stake in Mylan ($MYL) by 16% during the first quarter to $575 million. News

> A Pfizer ($PFE) study using functional MRI found that its pain drug Lyrica decreased connectivity between various parts of the brain involved in pain processing. Article

> Teva Pharmaceutical Industries ($TEVA) re-elected Chairman Philip Frost for a second three-year term. Item

> Johnson & Johnson ($JNJ) won a legal dispute with a distributor in China. Article

> Actavis won FDA approval for its version of GlaxoSmithKline's ($GSK) Parkinson's disease treatment Requip XL. Report

Biotech News

 @FierceBiotech: Celery extract shrinks difficult breast cancer tumor in mouse trials. Article | Follow @FierceBiotech

 @JohnCFierce: Scrap drug patents in favor of drug prizes? Vermont's Bernie Sanders draws up another fun bill with no hope of success. More | Follow @JohnCFierce

> iPierian salvages new game plan after stem cell tech loses its sizzle. Story

> AstraZeneca pulling out all stops in R&D deal frenzy. News

> User fee legislation promises better access, speedier reviews at FDA. More

> FDA staff backs J&J's Xarelto for heart condition. Article

Medical Devices News

 @FierceMedDev: The FDA is planning a summit on how to build a better hospital glucose sensor. Block off June 25 on your calendars. More | Follow @FierceMedDev

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Covidien recalls Roticulator staplers. Story

> ResMed hits the 1,000-patient milestone for apnea device study. More

> Biotronik's drug-coated balloon wows with promising 6-month results. Article

Biotech IT News

 @RyanMFierce: Click on #FBITchat & tune in for my chat with @Medidata's @CaptainClinical on innovations in clinical trials tomorrow. More | Follow @RyanMFierce

> Accelrys snaps up discovery software from Scynexis. More

> Ex-Apple CEO forecasts tech-driven change in medicine. News

> Startup Knode takes off with pharma fuel. Story

And Finally... Do the benefits of statin use in healthy adults over 50 outweigh the risk of side effects? Report